bococizumab

Argus has downgraded Pfizer Inc. (NYSE: PFE) to Hold from Buy on a weaker outlook, pipeline setbacks and increased competition. Further, the discontinuation of separation plans was also a key reason behind the downgrade, as the brokerage believes the split would have improved business performance...